Indiana Hemophilia &Thrombosis Center, Inc.
4 clinical trials · Sponsor
◉ Watch Indiana Hemophilia &Thrombosis Center, Inc.
| Record | Firm | Date |
|---|---|---|
| Metformin Use in Cardiac Fibrosis in PAI-1 Deficiency (NCT05317806) | Indiana Hemophilia &Thrombosis Center, Inc. | 2022-10-10 |
| Hemlibra in Mild Hemophilia A (NCT04567511) | Indiana Hemophilia &Thrombosis Center, Inc. | 2022-07-25 |
| HemLibra Prophylaxis in Patients With Hemophilic Pseudotumor (NCT03921294) | Indiana Hemophilia &Thrombosis Center, Inc. | 2019-05-15 |
| Study of Individuals Affected With Hypoplasminogenemia (NCT03797495) | Indiana Hemophilia &Thrombosis Center, Inc. | 2018-12-18 |
Track Indiana Hemophilia &Thrombosis Center, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.